Teamwork Financial Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Sell
5,091
-95,033
-95% -$4.08M 0.02% 176
2026
Q1
$3.68M Buy
100,124
+1,458
+1% +$69.1K 0.39% 64
2025
Q4
$5.02M Buy
98,666
+69,120
+234% +$3.53M 0.51% 54
2025
Q3
$1.64M Buy
29,546
+11,158
+61% +$653K 0.17% 86
2025
Q2
$1.27M Sell
18,388
-13,495
-42% -$918K 0.15% 93
2025
Q1
$2.21M Buy
31,883
+27,431
+616% +$2.27M 0.29% 63
2024
Q4
$383K Sell
4,452
-1,625
-27% -$176K 0.05% 124
2024
Q3
$724K Sell
6,077
-63,393
-91% -$8.45M 0.1% 87
2024
Q2
$9.92M Buy
+69,470
New +$9.21M 1.47% 29

Other funds holding NVO

Teamwork Financial Advisors's NVO Position: Q2 2026 in Review

Teamwork Financial Advisors reduced its Novo Nordisk (NVO) stake by 95% in Q2 2026, selling an estimated $4.08M and leaving 5,091 shares worth $244K. The position accounts for 0.02% of the portfolio, ranked #176.

Teamwork Financial Advisors first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.92M in Q2 2024. 205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Teamwork Financial Advisors held 5,091 shares of Novo Nordisk worth $244K as of Q2 2026.
  • Teamwork Financial Advisors sold 95,033 Novo Nordisk shares in Q2 2026, an estimated $4.08M.
  • Novo Nordisk made up 0.02% of Teamwork Financial Advisors's portfolio in Q2 2026, its #176 holding.
  • Teamwork Financial Advisors first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
  • Teamwork Financial Advisors's Novo Nordisk position peaked at $9.92M in Q2 2024.
  • 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Teamwork Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.